Press-release for stocks

Prices are updated after-hours

Data from Medivir's MIV-818 phase 1b study to be presented at the ESMO Congress
Published: 2021-08-05 (Crawled : 08:00) - prnewswire.com
IGMS | $6.75 -6.25% -6.43% 240K

| -90.24% | O: -0.49% H: 15.53% C: 14.73%
phase 1 phase 1b phase 2b

72%

28%

AGBA | $2.5 100.0% 58.33% 200M

EDBL | News | $6.26 66.49% 48.56% 270K

MLEC | $2.47 76.43% 38.05% 460K

PEGY | $0.0458 -10.2% 28.77% 79M

PALI | $4.93 4.67% 25.83% 2.1M

SILO | $1.99 0.71% 20.64% 1.8M

NNVC | $1.12 1.82% 19.64% 2.5K

CANG | $1.34 -4.29% 14.93% 120K

AZTR 4 | $0.195 13.85% 42K

TOVX | News | $0.411 -1.01% 12.9% 230K

Save your searches and get alerts when important news are released.